Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Multiple sclerosis progression: time for a new mechanism-driven framework
Tanja Kuhlmann, Marcello Moccia, Timothy Coetzee, et al.
The Lancet Neurology (2022) Vol. 22, Iss. 1, pp. 78-88
Open Access | Times Cited: 336

Showing 26-50 of 336 citing articles:

Disentangling the heterogeneity of multiple sclerosis through identification of independent neuropathological dimensions
Alyse de Boer, Aletta M.R. van den Bosch, Nienke Mekkes, et al.
Acta Neuropathologica (2024) Vol. 147, Iss. 1
Open Access | Times Cited: 10
The effects of intermittent fasting for patients with multiple sclerosis (MS): a systematic review
Xiaoxiao Lin, Shuai Wang, Yue Gao
Frontiers in Nutrition (2024) Vol. 10
Open Access | Times Cited: 9
The ageing central nervous system in multiple sclerosis: the imaging perspective
Massimo Filippi, Paolo Preziosa, Frederik Barkhof, et al.
Brain (2024) Vol. 147, Iss. 11, pp. 3665-3680
Open Access | Times Cited: 9
Significance of Programmed Cell Death Pathways in Neurodegenerative Diseases
Dong Guo, Zhihao Liu, Jinglin Zhou, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 18, pp. 9947-9947
Open Access | Times Cited: 8
Healthcare use is elevated two decades before a first demyelinating event and differs by age and sex
Helen Tremlett, Feng Zhu, Karl Everett, et al.
Annals of Clinical and Translational Neurology (2025)
Open Access | Times Cited: 1
Towards a biological view of multiple sclerosis from early subtle to clinical progression: an expert opinion
Massimo Filippi, Maria Pia Amato, Carlo Avolio, et al.
Journal of Neurology (2025) Vol. 272, Iss. 2
Open Access | Times Cited: 1
Recent advances in mesenchymal stem cell therapy for multiple sclerosis: clinical applications and challenges
Kamran Sheikhi, Sara Ghaderi, Hassan Firouzi, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 13
Open Access | Times Cited: 1
Ginsenoside Rb1 alleviates blood-brain barrier damage and demyelination in experimental autoimmune encephalomyelitis mice by regulating JNK/ ERK/NF-κB signaling pathway
Yingying Song, Xiaojuan Zhang, Xinyan Han, et al.
Journal of Ethnopharmacology (2025), pp. 119448-119448
Closed Access | Times Cited: 1
Multifaceted Biomarkers Suggest a Similar Profile of CNS Pathology in Relapsing and Progressive MS
Katelijn M. Blok, Romy A. M. Klein Kranenbarg, Kirtana Ananth, et al.
European Journal of Neurology (2025) Vol. 32, Iss. 2
Open Access | Times Cited: 1
Efficacy and safety of mesenchymal stromal cell transplantation in the treatment of autoimmune and rheumatic immune diseases: a systematic review and meta-analysis of randomized controlled trials
Liuting Zeng, Chang Liu, Yang Wu, et al.
Stem Cell Research & Therapy (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Cellular rejuvenation protects neurons from inflammation-mediated cell death
Sienna Drake, Abdulshakour Mohammadnia, Aliyah Zaman, et al.
Cell Reports (2025) Vol. 44, Iss. 2, pp. 115298-115298
Open Access | Times Cited: 1
Evolution of Chronic Lesion Tissue in Relapsing-Remitting Patients With Multiple Sclerosis
Samuel Klistorner, Michael Barnett, John DE Parratt, et al.
Neurology Neuroimmunology & Neuroinflammation (2025) Vol. 12, Iss. 3
Closed Access | Times Cited: 1
Building a monitoring matrix for the management of multiple sclerosis
Isabel Voigt, Hernán Inojosa, Judith Wenk, et al.
Autoimmunity Reviews (2023) Vol. 22, Iss. 8, pp. 103358-103358
Closed Access | Times Cited: 18
Mechanosensitive Piezo1 channel in physiology and pathophysiology of the central nervous system
Boyi Zong, Fengzhi Yu, Xiaoyou Zhang, et al.
Ageing Research Reviews (2023) Vol. 90, pp. 102026-102026
Open Access | Times Cited: 18
Toward identifying key mechanisms of progression in multiple sclerosis
Leila Husseini, Anastasia Geladaris, Martin S. Weber
Trends in Neurosciences (2023) Vol. 47, Iss. 1, pp. 58-70
Open Access | Times Cited: 17
Proteomic signatures of physical, cognitive, and imaging outcomes in multiple sclerosis
Kian Jalaleddini, Dejan Jakimovski, Anisha Keshavan, et al.
Annals of Clinical and Translational Neurology (2024) Vol. 11, Iss. 3, pp. 729-743
Open Access | Times Cited: 8
MS care: integrating advanced therapies and holistic management
Gavin Giovannoni, Helen Ford, Klaus Schmierer, et al.
Frontiers in Neurology (2024) Vol. 14
Open Access | Times Cited: 8
The Impact of Microbiota–Immunity–Hormone Interactions on Autoimmune Diseases and Infection
Serena Martinelli, Giulia Nannini, Fabio Cianchi, et al.
Biomedicines (2024) Vol. 12, Iss. 3, pp. 616-616
Open Access | Times Cited: 8
Managing multiple sclerosis in individuals aged 55 and above: a comprehensive review
Óscar Fernández, Per Soelberg Sørensen, Gıancarlo Comı, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 8
A metformin add-on clinical study in multiple sclerosis to evaluate brain remyelination and neurodegeneration (MACSiMiSE-BRAIN): study protocol for a multi-center randomized placebo controlled clinical trial
Anna-Victoria De Keersmaecker, Eline Van Doninck, Veronica Popescu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 8
In-silico studies of phytoconstituents of Bacopa monnieri and Centella asiatica with Crystal structure of Myelin Oligodendrocyte Glycoprotein against primary demyelination in Multiple Sclerosis
Aaryan Gupta, Arpita Roy, Vaseem Raja, et al.
Journal of Integrated Science and Technology (2024) Vol. 12, Iss. 3
Open Access | Times Cited: 7
Persons with multiple sclerosis older than 55 years: an analysis from the German MS registry
Yasemin Goereci, David Ellenberger, Paulus Rommer, et al.
Journal of Neurology (2024) Vol. 271, Iss. 6, pp. 3409-3416
Open Access | Times Cited: 7
Assessing disease progression and treatment response in progressive multiple sclerosis
Gıancarlo Comı, Gloria Dalla Costa, Bruno Stankoff, et al.
Nature Reviews Neurology (2024) Vol. 20, Iss. 10, pp. 573-586
Closed Access | Times Cited: 7
Adverse Childhood Experiences and the Risk of Multiple Sclerosis Development: A Review of Potential Mechanisms
Karine Eid, Marte‐Helene Bjørk, Nils Erik Gilhus, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1520-1520
Open Access | Times Cited: 6
Prognostic relevance of MRI in early relapsing multiple sclerosis: ready to guide treatment decision making?
Olaf Hoffmann, Ralf Gold, Sven G. Meuth, et al.
Therapeutic Advances in Neurological Disorders (2024) Vol. 17
Open Access | Times Cited: 6

Scroll to top